These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2842632)

  • 1. Platelet cGMP-binding phosphodiesterase.
    Hamet P; Tremblay J
    Methods Enzymol; 1988; 159():710-22. PubMed ID: 2842632
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
    Grant PG; Mannarino AF; Colman RW
    Thromb Res; 1990 Jul; 59(1):105-19. PubMed ID: 2169075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP binding and cyclic GMP phosphodiesterase in rat platelets.
    Hamet P; Coquil JF
    J Cyclic Nucleotide Res; 1978 Aug; 4(4):281-90. PubMed ID: 82561
    [No Abstract]   [Full Text] [Related]  

  • 5. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
    Robichon A
    J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of cGMP-binding protein phosphodiesterase from rat lung.
    Francis SH; Corbin JD
    Methods Enzymol; 1988; 159():722-9. PubMed ID: 2842633
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification of bovine retinal cGMP phosphodiesterase.
    Tar A; Ting TD; Ho YK
    Methods Enzymol; 1994; 238():3-12. PubMed ID: 7799796
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.
    Taylor PM; Heptinstall S
    Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
    Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
    [No Abstract]   [Full Text] [Related]  

  • 10. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
    Yamakado T; Tanaka F; Hidaka H
    Biochim Biophys Acta; 1984 Sep; 801(1):111-6. PubMed ID: 6147162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a light-activated rod outer segment phosphodiesterase.
    Yamazaki A; Miki N; Bitensky MW
    Methods Enzymol; 1982; 81():526-32. PubMed ID: 6285126
    [No Abstract]   [Full Text] [Related]  

  • 12. Photoaffinity labeling of high-affinity cGMP-specific noncatalytic binding sites on cGMP phosphodiesterase of rod outer segments.
    Yamazaki A; Bitensky MW; Casnellie JE
    Methods Enzymol; 1988; 159():730-6. PubMed ID: 2842634
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization and metabolism of cyclic guanosine 3'5'-monophosphate in Mycobacterium smegmatis.
    Bhatnagar NB; Bhatnagar R; Venkitasubramanian TA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):634-40. PubMed ID: 6145417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and comparison of bovine heart cGMP-inhibited and cGMP-stimulated phosphodiesterases.
    Harrison SA; Beier N; Martins TJ; Beavo JA
    Methods Enzymol; 1988; 159():685-702. PubMed ID: 2842630
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
    Tang KM; Jang EK; Haslam RJ
    Eur J Pharmacol; 1994 Jun; 268(1):105-14. PubMed ID: 7925608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous assay of cyclic AMP and cyclic GMP phosphodiesterase activity by anion-exchange column chromatography.
    Hsu DS; Chen SS
    J Chromatogr; 1982 Aug; 245(3):369-72. PubMed ID: 6290518
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
    Kincaid RL; Manganiello VC
    Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclic guanosine 3',5'-monophosphate and phosphodiesterase activity in mitogen-stimulated human lymphocytes.
    Takemoto DJ; Kaplan SA; Appleman MM
    Biochem Biophys Res Commun; 1979 Sep; 90(2):491-7. PubMed ID: 41522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.